a massive sell off, page-100

What u going to do 2morrow? I think SRX will make a bound full and bounty full recovery. You still want to go on shorting. It might even get back to $28 if you look at the T/A, volume patterns b4 the traders bought it off the back of broker recs. It is a big call, granted, but the results show a company far away from sick, in fact the results should be revenue enhancing and take down the PE ratio to something in the 30s or even 20s (not that PE ratios should be used to buy or sell biopharma stocks in any event). Liver cancer is one of the big cancers of Asia, Old Europe, US and Australasia, so SRX has a good future ahead, I would have thought.